recurrent endometrial cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (2)

Phase 2 (1)
Phase 3 (1)

Interventional (2)

Alessandro Santin (1)
AstraZeneca (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcancer

I am/have/hadmeasurable disease

I am/have/hadendometrial cancer

I am/have/hadneuropathy

I am/have/hadendometrial carcinoma

I am/have/hadcarcinoma

I am/have/hadrecurrent endometrial cancer

I am/have/hadct scan

I am/have/hadx-rays

I am/have/hadcarcinosarcoma

I am/have/hadcancer therapy

I am/have/hadnon-target

I am/have/hadhair thinning

I am/have/hadrenal function

I am/have/hadliver metastasis

I am/have/hadserum pregnancy test

I am/have/hadascites

I am/have/hadcarboplatin paclitaxel

I am/have/hadrecurrent disease

I am/have/hadmajor surgery

added new label for I am/have/had

more

I am looking for

I am looking forhormone therapy

I am looking forx-rays

I am looking foradjuvant

I am looking forcarboplatin

I am looking forplatinum-based chemotherapy

I am looking forcorticosteroids

I am looking forolaparib

I am looking forpaclitaxel

I am looking fordurvalumab

I am looking forprednisone

I am looking forimmunomodulators

I am looking forendocrine therapy

I am looking forimmunomodulator

I am looking forsacituzumab govitecan

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Family Medicine
Recruiting

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

durvalumab

cancer

recurrent disease

endometrial cancer

measurable disease

0 views
16 Feb, 2024
95 locations

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Family Medicine
Recruiting

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

cancer

hair thinning

renal function

pleural effusions

recurrent disease

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.